OOIR: Observatory of International Research

Papers

(The median citation count of Presse Medicale is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Editorial	42
Editorial board	41
Contents	36
Long-COVID: Cognitive deficits (brain fog) and brain lesions in non–hospitalized patients	33
Kidney disease in multiple myeloma	32
Autoimmunity in lipodystrophy syndromes	29
International variability in the diagnosis and management of disorders of consciousness	27
History of measles	24
Primary cutaneous lymphoma: the 2018 update of the WHO-EORTC classification	21
Editorial board	19
New developments in skin-directed treatments of cutaneous T-cell lymphoma	19
Evolving strategies in the management of transplant-eligible patients with newly diagnosed multiple myeloma	18
Craniopharyngiomas	18
Editorial board	18
Familial partial lipodystrophy syndromes	18
Molecular Imaging in neuroendocrine neoplasias	17
Editorial board	17
Pulmonary hypertension in sickle cell disease	17
Updates on mechanisms of disease progression in precursor myeloma: Monoclonal gammopathy of undermined significance and smoldering myeloma	16
Towards etiological treatments in cardiomyopathies	16
Presentation of polymyalgia rheumatica and large joint polyarthritis in the spectrum of hyper-IgG4-related disease: A case report and literature review	15
Prognosis of consciousness disorders in the intensive care unit	13
The deep and the deeper: Spinal cord and deep brain stimulation for neuropathic pain	13
Cholera in Haiti	12
Editorial board	12

The current and future contribution of neuroimaging to the understanding of disorders of consciousness	12
Editorial board	11
Heart failure with preserved ejection fraction: New challenges and new hopes	11
Cystic fibrosis	11
Renal hemodynamic changes in patients with type 2 diabetes and their clinical impact	10
Heart failure: A major public health problem	10
Update on brain MRI for the diagnosis and follow-up of MS patients	9
Generalized lipoatrophy syndromes	9
Cardiac functional imaging	9
Contents	8
COVID-19 and kidney transplantation	8
Contents	8
Contents	8
Letter on the article “Long-COVID: Cognitive deficits (brain fog) and brain lesions in non hospitalized patients”	8
Risk stratification of acute pulmonary embolism	7
Elderly patients with venous thromboembolism: Insights from the RIETE registry	7
Adrenal functional imaging	7
The Spanish flu	7
A tribute to Guy Meyer	6
Imaging in multiple myeloma	6
Sickle cell disease and pregnancy	6
Prolactinomas	5
Metreleptin treatment of non-HIV lipodystrophy syndromes	5
Contents	5
Pituitary adenoma & nuclear medicine: Recent outcomes and ongoing developments	5
Bronchiectasis	4
Idiopathic pulmonary fibrosis	4
Contents	4
Diagnostic management of acute pulmonary embolism	4
The liver in sickle cell disease	4
Rehabilitation in multiple sclerosis in 2021	4
Health technology assessment in France	4
Preventative and curative treatment of venous thromboembolic disease in cancer patients	4
Multiple sclerosis diagnostic criteria: From poser to the 2017 revised McDonald criteria	4
Vascular pathophysiology of sickle cell disease	4
New concepts on immunology of Multiple Sclerosis	3
Treatment of elderly and frail myeloma patients	3
Lower-limb peripheral arterial disease and amputations in people with diabetes: Risk factors, prognostic value and management	3
Functional imaging in thyroid cancer patients with metastases and therapeutic implications	3
Duration of anticoagulation of venous thromboembolism	3
What's new in transplantation?	3
HIV / AIDS as a model for emerging infectious disease: Origin, dating and circumstances of an emblematic epidemiological success	3
Life and death of smallpox	3
Patient-reported outcome measures: A key to patient-tailored and outcome-driven care in pulmonary embolism survivors	2
Molecular imaging or functional: An increasingly applied method in all fields of medicine	2
Primary ciliary dyskinesia	2
The French way of HTA: between scientific rigour, independence and transparency	2
Electrical therapies in heart failure: Evolving technologies and indications	2
Recent insights in pituitary diseases	2
Functional imaging for hyperparathyroidism	2

Advancing the management of acute intermediate-high-risk pulmonary embolism: The enduring legacy of Professor Guy Meyer	2
Editorial	2
Clinical trials with reno-vascular end points in patients with diabetes: Changing the scenario over the past 20 years	2
Hypophysitis: A comprehensive overview	2
Clinical pharmacology of antidiabetic drugs: What can be expected of their use?	2
Contents	2
Contents	2
Editorial	2
Cushing's disease	2
The European reference network on rare lung diseases (ERN-LUNG) ambition to offer better lung health for all	2
Neuropathic pain: Evidence based recommendations	2
Bispecific antibody and chimeric antigen receptor (CAR) modified T-cell in the treatment of multiple myeloma: Where do we stand today?	2
Fecal microbiota transplantation: History, procedure and regulatory considerations	1
Chronic heart failure with reduced EF: A decade of major pharmacological innovations	1
Features of an adrenal cortical carcinoma on CT scan: A case report	1
Lymphangioleiomyomatosis	1
The ongoing challenge of RBC alloimmunization in the management of patients with sickle cell disease	1
The PROCLIPI international registry, an important tool to evaluate the prognosis of cutaneous T cell lymphomas	1
Editorial board	1
Yellow fever: A brief history of a tropical Virosis	1
Editorial	1
Multiple symmetric and multiple familial lipomatosis	1
End-stage heart failure: The future of heart transplant and artificial heart	1
Optimising recovery of consciousness after coma. From bench to bedside and vice versa	1
Covid-19, an unfinished story	1
Gene-addition/editing therapy in sickle cell disease	1
French Vasculitis Study Group recommendations for the management of COVID-19 vaccination and prophylaxis in patients with systemic vasculitis	1
Taking ethics into account: the HAS perspective	1
Health Technology Assessment in Europe: a comparison of organizations and introduction to the European regulation	1
Laboratory-associated infections and biosafety	1
French reimbursement of health technologies: assessment is at the heart of the procedure	1
Contents	1
Severity of kidney involvement as predictor of death, severe heart failure and renal events in patients with type 2 diabetes: Data from a prospective cohort	1
Editorial board	1